602.09MMarket Cap-6351P/E (TTM)
12.300High11.380Low1.44MVolume11.870Open11.870Pre Close16.77MTurnover4.53%Turnover RatioLossP/E (Static)52.08MShares30.99052wk High2.26P/B366.20MFloat Cap5.67052wk Low--Dividend TTM31.68MShs Float72.200Historical High--Div YieldTTM7.75%Amplitude2.190Historical Low11.683Avg Price1Lot Size
EyePoint Pharmaceuticals Stock Forum
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet